4th Global NITAG Network (GNN) meeting

Estados Unidos
10 Diciembre 2019

The 4th GNN meeting will build on the NITAG support strategy developed by WHO Headquarters and Regional Offices with the support of network partners.

The GNN meeting will be conducted in conjunction with the ACIP meeting this year.

The aim of this GNN meeting is to:
•Review the Global NITAG Network activities and regional support to NITAGs.
•Strengthen NITAGs in their abilities to make evidence based policy decisions.
•Identify priority activities for the GNN and its global partners.

ACIP meeting:
Participants will observe ACIP workgroup presentations and NITAG deliberations. Facilitated discussions with ACIP Secretariat members regarding ACIP processes will also occur.

Información práctica
24-26 Febrero 2020
US-Center for Disease Control
Emory Conference Center

Noticias y eventos relacionados

  • Red

    Results from the NITAG off-label recommendations study


    In 2017, NITAG members participating in the second Global NITAG Network meeting in Berlin raised the issue of off label recommendations and requested a survey on this topic. A team from Dalhousie University led by Karina Top and Noni MacDonald conducted the study. 

    Leer más
  • Estados Unidos

    ACIP releases the 2017 adult and childhood immunization schedules


    The CDC and its Advisory Committee on Immunization Practices (ACIP), together with the AAFP and other medical professional organizations, have released the 2017 adult and childhood immunization schedules.

    Leer más
  • Estados Unidos

    CDC Advisory Committee On Immunization Practices Votes To Recommend Vaxchora, PaxVax’s Single-Dose Oral Cholera Vaccine


    The ACIP voted unanimously at their June 22 meeting to recommend Vaxchora for the prevention of toxigenic Vibrio cholerae O1 for travelers to areas of active cholera transmission. The Category A recommendation made by the ACIP for Vaxchora will be forwarded to the director of the CDC and the U.S. Department of Health and Human Services for review and approval. Once approved, the recommendations will be published in the Morbidity and Mortality Weekly Report (MMWR). Category A recommendations are made for all persons in an age- or risk-factor-based group.

    Leer más